Efficacy and Duration of Action of the Four Selective Angiotensin II Subtype 1 Receptor Blockers, Losartan, Candesartan, Valsartan and Telmisartan, in Patients with Essential Hypertension Determined by Home Blood Pressure Measurements

References

• 1999 World Health Organization–International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines subcommittee. J Hypertens 1999; 17:151–183. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289:2560–2572. [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Guidelines Committee. 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011–1053.
   PubMed Web of Science ®Google Scholar
• Guidelines Subcommittee of the Japanese Society of Hypertension. Guidelines for the Management of Hypertension (JSH 2004). Japanese Society of Hypertension. Life Science Publisher, 2004.
   Google Scholar
• Staessen J A, Thijs L, Clement D, Davidson C, Fagard R, Lehtonen A, Mancia G, Palatini P, O'Brien E T, Parati G, Webster J, Antoon A, on behalf of the Syst-Eur investigators. Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. Syst-Eur investigators. J Hypertens 1994; 12:1035–1039. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Imai Y. Clinical significance and cost-effectiveness of 24-hour ambulatory blood pressure monitoring. Tohoku J Exp Med 1995; 176:1–15. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Asmar R, Safar M, Queneau P. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens 2001; 14:546–552. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Imai Y, Ohkubo T, Hozawa A, Tsuji I, Matsubara M, Araki T, Chonan K, Kikuya M, Satoh H, Hisamichi S, Nagai K. Usefulness of home blood pressure measurement in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19:179–185. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Kikuya M, Ito S, Satoh H, Hisamichi S. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16:971–975. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Ohasama study. How many times should blood pressure be measured at home for better prediction of stroke risk? 10-year follow-up results from the Ohasama study. J Hypertens 2004; 22:1099–1104. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Menard J, Chattelier G, Day M, Vahul L. Self-measurement of blood pressure measured at home to evaluate drug effects by the trough peak ratio. J Hypertens 1994; 12(suppl 8):S21–S25. [CSA]
   Google Scholar
• Hashimoto J, Chonan K, Aoki Y, Ugajin T, Yamaguchi J, Nishimura T. Therapeutic effects of evening administration of guanabenz and clonidine on morning hypertension: evaluation using home-based blood pressure measurements. J Hypertens 2003; 21:805–811. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K, Japanese Society of Hypertension. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26:771–782. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Benetos A, Safar M, Rudnichi A, Smulyan H, Richard J L, Ducimetieere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30:1410–1415. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32:983–988. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• O'Brien E, Waeber B, Parati G, Staessen G, Myer M G, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Blood pressure measuring devices: recommendations of the European Society of Hypertension. Br Med J 2001; 322:531–536.
   PubMed Web of Science ®Google Scholar
• Mallion J, Siche J, Lacourciere Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999; 13:657–664. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Littlejohn T, Mroczek W, Marbury T, VanderMaelen C P, Dubiel R F. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Can J Cardiol 2000; 16:1123–1132., [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wong P C, Price W A Jr., Chiu A T, Duncia J V, Carini D J, Wexler R R, Johnson A L, Timmermans P B. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990; 255:211–217. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens 1995; 13:1105–1112. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Omboni S, Fogari R, Palatini P, Rappelli A, Mancia G. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study. Hypertension 1998; 32:424–429. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fogari R, Mugellini A, Zoppi A, Derosa G, Rinaldi A, Fogari E, Vanasia A, Preti P. Efficacy of losartan, valsartan, and telmisartan in patients with mild to moderate hypertension: a double-blind, placebo-controlled, crossover study using ambulatory blood pressure monitoring. Curr Ther Res Clin Exp 2002; 63:1–14. [CROSSREF]
   Web of Science ®Google Scholar
• Stergiou G S, Efstathiou S P, Argyraki C K, Gantzarou A P, Roussias L G, Mountokalakis T D. Clinic, home and ambulatory pulse pressure: comparison and reproducibility. J Hypertens 2002; 20:1987–1993. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Franklin S S, Khan S A, Wong N D, Larson M G, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 1999; 100:354–360. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Franklin S S, Larson M G, Khan S A, Wong N D, Leip E P, Kannel W B, Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham heart study. Circulation 2001; 103:1245–1249. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gerdts E, Papademetriou V, Palmieri V, Boman K, Bjornstad H, Wachtell K, Giles T D, Dahlof B, Devereux R B. Losartan intervention for end point (LIFE) reduction in hypertension study. Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 2002; 89:399–402. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lindholm L H, Ibsen H, Dahlof B, Devereux R B, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen S E, Kristiansson K, Lederballe-Pedersen O, Nieminen M S, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S, LIFE Study Group. The LIFE study group. Losartan Intervention For Endpoint (LIFE) reduction in hypertension study: a randomized trial against atenolol. Lancet 2002; 359:1004–1010. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar